Abstract:The NLRP3 (NLR family pyrin domain containing 3) inflammasome is involved in diverse inflammatory diseases, thus strict control of its activation is necessary to prevent excessive inflammation. Protein ubiquitination has been reported to regulate the assembly, protein expression and activation of the NLRP3 inflammasome. Until now, several deubiquitinases (DUBs) have been reported to affect the degradation of NLRP3 through the proteasome pathway. However, there is no research on DUBs regulating NLRP3 degradation through macroautophagy/autophagy. Here, we demonstrated the pivotal function of USP5 (ubiquitin specific peptidase 5) in restraining the activation of the NLRP3 inflammasome independent of its deubiquitinating enzyme activity. USP5 selectively promoted K48-linked polyubiquitination of NLRP3 and mediated its degradation through the autophagy-lysosomal pathway by recruiting the E3 ligase MARCHF7/MARCH7. Knockdown of USP5 facilitated the two-signal model of lipopolysaccharide and ATP-triggered IL1B/IL-1β production. Simultaneously, USP5 overexpression in vivo reduced IL1B and polymorphonuclear (PMN) infiltration in alum-induced peritonitis. Overall, the data revealed that USP5 is a key scaffold protein recruiting the E3 ligase MARCHF7 to NLRP3, and promoting autophagic degradation of NLRP3. The findings provide new insight into USP5 in the regulation of excessive activation of the NLRP3 inflammasome and inflammatory innate immune response. 3-MA: 3-methyladenine; AIM2: absent in melanoma 2; ATG5: autophagy related 5; BafA1: bafilomycin A1; CASP1: caspase 1; CHX: cycloheximide; Co-IP: co-immunoprecipitation; CQ: chloroquine; DUBs: deubiquitinases; IL1B/IL-1β: interleukin 1 beta; LAMP1: lysosomal associated membrane protein 1; LPS: lipopolysaccharide; MARCHF7/MARCH7: membrane associated RING-CH-type finger 7; NFKB/NF-κB: nuclear factor kappa B; Nig.: nigericin; NLRC4: NLR family CARD domain containing 4; NLRP3: NLR family pyrin domain containing 3; PECs: peritoneal exudate cells; PMN: polymorphonuclear; PMs: peritoneal macrophages; PYCARD/ASC: PYD and CARD domain containing; TLRs: toll like receptors; TNF/TNF-α: tumor necrosis factor; Ub: ubiquitin; USP5: ubiquitin specific peptidase 5; WT: wild type.

Palmitoylation promotes chaperone-mediated autophagic degradation of NLRP3 to modulate inflammation

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

Palmitoylation of NLRP3 Modulates Inflammasome Activation and Inflammatory Bowel Disease Development.

ZDHHC5-mediated NLRP3 Palmitoylation Promotes NLRP3-NEK7 Interaction and Inflammasome Activation.

Palmitoylation Facilitates Inflammation Through Suppressing NOD2 Degradation Mediated by the Selective Autophagy Receptor SQSTM1.

Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation

NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation

The regulation of NLRP3 inflammasome activation by CCDC50-mediated autophagy

Palmitoylation Restricts SQSTM1/p62-mediated Autophagic Degradation of NOD2 to Modulate Inflammation

ABHD8 antagonizes inflammation by facilitating chaperone-mediated autophagy-mediated degradation of NLRP3

Posttranslational Modifications of NLRP3 and Their Regulatory Roles in Inflammasome Activation

Regulation of NLRP3 Inflammasome by Phosphorylation

Fatty acid synthesis promotes inflammasome activation through NLRP3 palmitoylation

The Signaling Pathways Regulating NLRP3 Inflammasome Activation

CCDC50 Suppresses NLRP3 Inflammasome Activity by Mediating Autophagic Degradation of NLRP3

NLRP3 Negative Regulation Mechanisms in the Resting State and Its Implications for Therapeutic Development

Regulation of the NLRP3 inflammasome by autophagy and mitophagy

Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis

USP5 Attenuates NLRP3 Inflammasome Activation by Promoting Autophagic Degradation of NLRP3

Metabolic Regulation of the NLRP3 Inflammasome

NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners